Accessibility Menu
 
Cellectis logo

Cellectis

(OTC) CMVLF

Current Price$3.08
Market Cap$222.76M
Since IPO (2013)-34%
5 Year-84%
1 Year+146%
1 Month-30%

Cellectis Financials at a Glance

Market Cap

$222.76M

Revenue (TTM)

$73.04M

Net Income (TTM)

$67.83M

EPS (TTM)

$-0.67

P/E Ratio

-4.57

Dividend

$0.00

Beta (Volatility)

0.10 (Low)

Price

$3.08

Volume

72

Open

$3.08

Previous Close

$3.08

Daily Range

$3.08 - $3.08

52-Week Range

$1.25 - $5.04

CMVLF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cellectis

Industry

Biotechnology

Employees

229

CEO

André Choulika, PhD

Headquarters

Paris, 75013, FR

CMVLF Financials

Key Financial Metrics (TTM)

Gross Margin

84%

Operating Margin

-48%

Net Income Margin

-93%

Return on Equity

-65%

Return on Capital

-19%

Return on Assets

-21%

Earnings Yield

-21.88%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$222.76M

Shares Outstanding

72.33M

Volume

72

Short Interest

0.00%

Avg. Volume

6.387

Financials (TTM)

Gross Profit

$55.04M

Operating Income

$42.00M

EBITDA

$21.12M

Operating Cash Flow

$41.64M

Capital Expenditure

$2.46M

Free Cash Flow

$44.10M

Cash & ST Invst.

$208.67M

Total Debt

$119.91M

Cellectis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$10.49M

-17.5%

Gross Profit

$715.55K

-105.6%

Gross Margin

-6.82%

N/A

Market Cap

$222.76M

N/A

Market Cap/Employee

$1.03M

N/A

Employees

216

N/A

Net Income

$26.56M

-548.4%

EBITDA

$13.86M

-212.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$88.77M

-47.4%

Accounts Receivable

$22.20M

-3.6%

Inventory

$0.00

N/A

Long Term Debt

$101.74M

+30.0%

Short Term Debt

$18.16M

+37.3%

Return on Assets

-20.89%

N/A

Return on Invested Capital

-19.41%

N/A

Free Cash Flow

$11.06M

-517.3%

Operating Cash Flow

$10.58M

-22416.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HNSBFHansa Biopharma AB (publ)
$2.90+0.00%
HLOSFHealios K.K.
$2.30+0.00%
PBBIFProbi AB (publ)
$24.00+0.00%
TRGNFTransgene S.A.
$1.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$128.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$49.17+0.00%

Questions About CMVLF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.